Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
Collegium Pharmaceutical (Nasdaq: COLL), a diversified specialty pharmaceutical company, has announced it will release its second quarter 2024 financial results on August 8, 2024, after market close. The company will host a live conference call and webcast at 4:30 p.m. ET following the release. Investors can access the call by dialing (877) 407-8037 (U.S.) or (201) 689-8037 (International) and referencing the "Collegium Pharmaceutical Q2 2024 Earnings Call." An audio webcast will be available on the company's website, with a replay accessible approximately two hours after the event.
Collegium Pharmaceutical (Nasdaq: COLL), un'azienda farmaceutica specializzata e diversificata, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il 8 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica live e una web conference alle 16:30 ET dopo la divulgazione. Gli investitori possono accedere alla chiamata componendo il numero (877) 407-8037 (USA) o (201) 689-8037 (internazionale) e citando la
Collegium Pharmaceutical (Nasdaq: COLL), una compañía farmacéutica especializada y diversificada, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el 8 de agosto de 2024, después del cierre del mercado. La compañía organizará una llamada de conferencia en vivo y una transmisión web a las 4:30 p.m. ET tras la publicación. Los inversores pueden acceder a la llamada marcando (877) 407-8037 (EE.UU.) o (201) 689-8037 (internacional) y haciendo referencia a la "Collegium Pharmaceutical Q2 2024 Earnings Call." Una transmisión de audio estará disponible en el sitio web de la compañía, con una repetición accesible aproximadamente dos horas después del evento.
Collegium Pharmaceutical (Nasdaq: COLL)는 다양한 전문 제약 회사로, 2024년 2분기 재무 결과를 2024년 8월 8일 시장 종료 후 발표할 것이라고 발표했습니다. 이 회사는 발표 후 오후 4시 30분 ET에 라이브 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 투자자들은 (877) 407-8037 (미국) 또는 (201) 689-8037 (국제)로 전화하여 "Collegium Pharmaceutical Q2 2024 Earnings Call"을 언급함으로써 이 전화에 참여할 수 있습니다. 회사 웹사이트에서 오디오 웹캐스트를 이용할 수 있으며, 이벤트 후 약 2시간 뒤에 재생을 이용할 수 있습니다.
Collegium Pharmaceutical (Nasdaq: COLL), une entreprise pharmaceutique spécialisée et diversifiée, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le 8 août 2024, après la clôture des marchés. L'entreprise organisera une conférence téléphonique en direct et un webinaire à 16h30 ET après la publication. Les investisseurs pourront accéder à l'appel en composant le (877) 407-8037 (États-Unis) ou le (201) 689-8037 (international) et en faisant référence à "Collegium Pharmaceutical Q2 2024 Earnings Call." Un webinaire audio sera disponible sur le site web de l'entreprise, avec un replay accessible environ deux heures après l'événement.
Collegium Pharmaceutical (Nasdaq: COLL), ein diversifiziertes Spezial-Pharmaunternehmen, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am 8. August 2024 nach Börsenschluss veröffentlichen wird. Das Unternehmen wird im Anschluss an die Veröffentlichung eine Live-Konferenzschaltung und einen Webcast um 16:30 Uhr ET veranstalten. Investoren können die Telefonkonferenz unter (877) 407-8037 (USA) oder (201) 689-8037 (international) erreichen und sich auf die "Collegium Pharmaceutical Q2 2024 Earnings Call" beziehen. Ein Audio-Webcast wird auf der Website des Unternehmens verfügbar sein, mit einer Wiederholung, die etwa zwei Stunden nach der Veranstaltung zugänglich ist.
- None.
- None.
STOUGHTON, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:
Christopher James, M.D.
Vice President, Investor Relations
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com
FAQ
When will Collegium Pharmaceutical (COLL) report its Q2 2024 financial results?
How can investors access Collegium Pharmaceutical's (COLL) Q2 2024 earnings call?
What time is Collegium Pharmaceutical's (COLL) Q2 2024 earnings call scheduled for?
Where can I find the webcast for Collegium Pharmaceutical's (COLL) Q2 2024 earnings call?
